Halaman 3 - Metastasis di hati Dokter Terbaik - TOP-84 dokter

Prof. Wolfgang Köstler berspesialisasi dalam pengobatan kanker personal, dengan fokus pada keganasan payudara dan ginekologi. Karyanya dalam terapi terarah membantu menyesuaikan perawatan untuk hasil yang lebih baik.

• Lebih dari 20 tahun pengalaman di bidang onkologi medis
• Mantan Wakil Kepala Onkologi di Medical University of Vienna
• Pakar dalam pengembangan biomarker dan biologi tumor
• Konsultan senior di Wiener Privatklinik
• Aktif dalam jaringan onkologi Eropa dan uji klinis

Univ. Prof. Dr. Klaus Kaczirek adalah pakar terkemuka dalam bedah endokrin dan onkologi, yang berspesialisasi dalam prosedur kelenjar tiroid, paratiroid, dan adrenal.

• Pengalaman lebih dari 30 tahun dalam bedah endokrin dan visceral
• Profesor Bedah di Universitas Kedokteran Wina
• Spesialisasi dalam tumor neuroendokrin dan kanker penghasil hormon
• Publikasi luas mengenai biologi tumor endokrin dan teknik invasif minimal

Associate Professor Tahsin Ozatli adalah spesialis kanker payudara, paru-paru, dan gastrointestinal di Rumah Sakit Universitas Istinye Liv.

• Pengalaman lebih dari sepuluh tahun di bidang onkologi
• Bekerja di Klinik Onkologi Ankara dan Rumah Sakit Pelatihan dan Penelitian Regional Erzurum
• Diangkat menjadi Associate Professor pada tahun 2016

Spesialis dalam bedah laparoskopi untuk metastasis hati – menempuh pendidikan di program unggulan Universitas Istanbul.

• Lebih dari 30 tahun pengalaman dalam bedah umum dan laparoskopi
• Pelatihan lanjutan dalam bedah bariatrik dan onkologi laparoskopi
• Anggota Asosiasi Bedah Turki

Assoc. Prof. Nail Paksoy spesialis dalam pengobatan metastasis hati di Rumah Sakit Medipol Bahçelievler, dengan penelitian luas di bidang onkologi.

• Tersertifikasi ESMO dalam Onkologi Medis
• Berpartisipasi dalam berbagai uji klinis internasional untuk pengobatan kanker
• Menerbitkan berbagai artikel tentang kanker metastatik
• Menjalani pelatihan Fellowship di Institut Onkologi Universitas Istanbul

Profesor Gul Alco menggabungkan 25+ tahun pengalaman onkologi radiasi dengan kepemimpinan akademik di universitas terkemuka di Turki.

• Spesialisasi dalam pengobatan metastasis hati menggunakan teknik radiasi presisi
• Profesor di Departemen Onkologi Radiasi Universitas Medipol Istanbul
• Menempuh pendidikan di Universitas Istanbul – fakultas kedokteran terkemuka di Turki
• Menyeimbangkan praktik klinis dengan mengajar calon ahli onkologi radiasi

Spesialis dalam Onkologi Medis dengan pelatihan di Universitas Akdeniz – Dr. Alemdar berfokus pada metastasis hati di Medical Park Antalya.

• Terlatih dalam Kedokteran Internal sebelum berspesialisasi dalam onkologi
• Pengalaman di beberapa rumah sakit terkemuka termasuk Universitas Akdeniz
• Peran saat ini di Kompleks Rumah Sakit Medical Park Antalya
• Anggota asosiasi onkologi profesional

Lebih dari 30 tahun spesialisasi dalam viroterapi – Dr. Jaunalksne menghadirkan pendekatan imunologis mutakhir untuk metastasis hati di Pallas Clinic.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada perawatan imunoterapi inovatif

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Spesialis dalam bedah kanker kompleks, termasuk metastasis hati, di Rumah Sakit Büyük Anadolu.

• Ahli dalam bedah pankreas dan saluran empedu
• Terampil dalam bedah onkologi dan payudara
• Berpengalaman dalam prosedur kanker lambung dan usus besar
• Melakukan bedah kanker tiroid dan bedah obesitas

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Profesor Rifaat Safadi memimpin unit penyakit hati di Hadassah Medical Center, mengkhususkan diri dalam perawatan hati tingkat lanjut dengan pengakuan internasional.

• Dilatih di bawah bimbingan Profesor Scott Friedman di Sinai School of Medicine di New York
• Anggota asosiasi studi hati internasional
• Menerima penghargaan atas penelitian tentang modulasi imun fibrosis hati
• Penulis berbagai artikel di bidang hepatologi
• Kepala unit penyakit hati di Hadassah Medical Center